Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Randy912
    Junior Member
    • Aug 2016
    • 2

    #1

    RankProduct - Is this a valid analysis?

    Hello,

    I analyzed a few GEO data sets that were on different microarray platforms using the RankProd R library.

    However, since the data sets were on different microarray platforms, they have different probe sets and hence there were tons of NAs in the all-inclusive expression set. The candidates I ended up taking from this analysis actually ended up working, but I'm wondering if this analysis is defensible.

    Thank you in advance for any insight
  • IonTom
    Member
    • Apr 2014
    • 32

    #2
    From my experience Rank Product test gives much better and reliable results than most parametric methods.

    To your question. You should limit both microarrays to the probes that are available on both platforms. Otherwise the number of probes will be different for both platforms and the ranks will not be comparable.

    But limiting the probe sets should help. If the probes are nor directly matchable,
    you could use the gene level expression for a comparison.

    Comment

    • Randy912
      Junior Member
      • Aug 2016
      • 2

      #3
      The microarray platforms have totally different probe annotations, so there are actually 0 probe sets shared across all platforms.

      When you say "use gene level expression," how do you change the probe set names to facilitate the matches? For example, let's say gene X has probes 38548_at in an affy array, and 294838 in an Illumina array, how do you modify them so that the comparison can be made?

      Thank you for your help.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Working...